Form 4: Koru Medical Systems: Director Compensation and Ownership Update

Koru Medical Systems, Inc. reports on director compensation and beneficial ownership changes involving Joseph M. Manko Jr. and affiliated entities.

Summary

• Joseph M. Manko Jr., a Director and 10% owner of Koru Medical Systems, Inc. (KRMD), along with affiliated entities Horton Capital Management, LLC, Horton Capital Partners, LLC, and Horton Capital Partners Fund, LP, have filed a Form 4 statement.
• The filing details the acquisition of 3,472 shares of common stock by Horton Capital Partners Fund, LP on June 30, 2026, as compensation for Mr. Manko's services as a Director for the quarter ended June 30, 2026.
• Following this transaction, Horton Capital Partners Fund, LP holds 5,069,541 shares of common stock, with beneficial ownership attributed to Horton Capital Management, LLC and potentially Horton Capital Partners, LLC.
• The filing clarifies that while investment and voting power are delegated to Horton Capital Management, LLC, Horton Capital Partners, LLC retains the right to assume discretionary authority, potentially making it a beneficial owner.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It reports routine director compensation and ownership changes without indicating significant positive or negative developments for the company's operations or financial health.

Positives

• Director compensation in the form of company stock aligns incentives between management and the company.
• The acquisition of shares by a significant stakeholder like Horton Capital Partners Fund, LP could indicate continued confidence in the company's prospects.
• The filing clearly outlines the beneficial ownership structure, providing transparency to investors.

Negatives

• The filing does not contain any negative financial or operational information, as it is a statement of changes in beneficial ownership.
• The disclaimer regarding beneficial ownership may create some ambiguity for investors seeking absolute clarity on control.

Risks

• Potential for conflicts of interest given the multiple entities and individuals involved in beneficial ownership and management.
• The disclaimer of beneficial ownership by reporting persons could be interpreted as an attempt to distance themselves from direct responsibility, although this is standard for such filings.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a report of past transactions.

Management Comments

• Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
• The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for directors and significant shareholders to report changes in their holdings. The compensation structure involving stock grants is common in the healthcare technology sector, aiming to retain talent and align interests.

Related Party Transactions

• The acquisition of 3,472 shares of common stock by Horton Capital Partners Fund, LP from Koru Medical Systems, Inc. as compensation for Mr. Manko's director services constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Increased transparency regarding director compensation and ownership structure. The stock grant could dilute ownership slightly but also aligns director interests with shareholders.
• Employees: Indirect impact through director alignment with company performance.
• Management: Reinforces the compensation structure for directors.

Next Steps

• Continued monitoring of beneficial ownership changes by Joseph M. Manko Jr. and affiliated entities.
• Tracking the performance of Koru Medical Systems, Inc. to assess the value of the granted shares.

Key Dates

Keywords

Koru Medical Systems, KRMD, Form 4, Beneficial Ownership, Director Compensation, Horton Capital Partners, SEC Filing, Insider Trading, Stock Acquisition